Anemia, Sickle Cell
"Anemia, Sickle Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
Descriptor ID |
D000755
|
MeSH Number(s) |
C15.378.071.141.150.150 C15.378.420.155 C16.320.070.150 C16.320.365.155
|
Concept/Terms |
Anemia, Sickle Cell- Anemia, Sickle Cell
- Anemias, Sickle Cell
- Sickle Cell Anemias
- Sickling Disorder Due to Hemoglobin S
- Sickle Cell Disease
- Cell Disease, Sickle
- Cell Diseases, Sickle
- Sickle Cell Diseases
- Sickle Cell Disorders
- Cell Disorder, Sickle
- Cell Disorders, Sickle
- Sickle Cell Disorder
- Hemoglobin S Disease
- Disease, Hemoglobin S
- Hemoglobin S Diseases
- Sickle Cell Anemia
|
Below are MeSH descriptors whose meaning is more general than "Anemia, Sickle Cell".
- Diseases [C]
- Hemic and Lymphatic Diseases [C15]
- Hematologic Diseases [C15.378]
- Anemia [C15.378.071]
- Anemia, Hemolytic [C15.378.071.141]
- Anemia, Hemolytic, Congenital [C15.378.071.141.150]
- Anemia, Sickle Cell [C15.378.071.141.150.150]
- Hemoglobinopathies [C15.378.420]
- Anemia, Sickle Cell [C15.378.420.155]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Anemia, Hemolytic, Congenital [C16.320.070]
- Anemia, Sickle Cell [C16.320.070.150]
- Hemoglobinopathies [C16.320.365]
- Anemia, Sickle Cell [C16.320.365.155]
Below are MeSH descriptors whose meaning is more specific than "Anemia, Sickle Cell".
This graph shows the total number of publications written about "Anemia, Sickle Cell" by people in this website by year, and whether "Anemia, Sickle Cell" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1980 | 0 | 1 | 1 | 1984 | 1 | 0 | 1 | 1986 | 1 | 0 | 1 | 1987 | 1 | 0 | 1 | 1989 | 1 | 0 | 1 | 1990 | 3 | 1 | 4 | 1991 | 1 | 0 | 1 | 1993 | 1 | 1 | 2 | 1994 | 0 | 1 | 1 | 1997 | 1 | 0 | 1 | 1999 | 1 | 0 | 1 | 2000 | 2 | 0 | 2 | 2001 | 1 | 2 | 3 | 2003 | 1 | 1 | 2 | 2004 | 2 | 1 | 3 | 2005 | 2 | 0 | 2 | 2006 | 1 | 0 | 1 | 2008 | 2 | 0 | 2 | 2009 | 4 | 0 | 4 | 2010 | 6 | 1 | 7 | 2011 | 2 | 1 | 3 | 2012 | 2 | 0 | 2 | 2013 | 1 | 1 | 2 | 2014 | 3 | 1 | 4 | 2015 | 4 | 1 | 5 | 2016 | 6 | 0 | 6 | 2017 | 4 | 1 | 5 | 2018 | 8 | 0 | 8 | 2019 | 2 | 0 | 2 | 2020 | 5 | 0 | 5 | 2021 | 2 | 0 | 2 | 2022 | 5 | 0 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Anemia, Sickle Cell" by people in Profiles.
-
Ross LF. 50 Years Ago in TheJournalofPediatrics: Points to Consider: Sickle Cell Screening. J Pediatr. 2022 12; 251:126.
-
Fuja C, Kothary V, Carll TC, Singh S, Mansfield P, Wool GD. Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab. Transfusion. 2022 07; 62(7):1446-1451.
-
Creary SE, Beeman C, Stanek J, King K, McGann PT, O'Brien SH, Liem RI, Holl J, Badawy SM. Impact of hydroxyurea dose and adherence on hematologic outcomes for children with sickle cell anemia. Pediatr Blood Cancer. 2022 06; 69(6):e29607.
-
Carll TC, Mariani R, Schafernak K, Snowberger T, Jacobsen J, Gomez E, Su L. Peripheral Blood Smear Detection of Asymptomatic Central Line Infection in a Patient With Sickle Cell Disease. J Pediatr Hematol Oncol. 2022 Apr 01; 44(3):98-99.
-
Wu HW, Rahim N, Mbadiwe N, Khayat S, da Fonseca MA, Peters E, Hsu LL. Vaso-occlusive Pain Crisis Mimicking Mandibular Abscess in an Adolescent with Sickle Cell Disease. J Pediatr Hematol Oncol. 2022 Mar 01; 44(2):e450-e452.
-
Alishlash AS, Sapkota M, Ahmad I, Maclin K, Ahmed NA, Molyvdas A, Doran S, Albert CJ, Aggarwal S, Ford DA, Ambalavanan N, Jilling T, Matalon S. Chlorine inhalation induces acute chest syndrome in humanized sickle cell mouse model and ameliorated by postexposure hemopexin. Redox Biol. 2021 08; 44:102009.
-
Lapping-Carr G, Gemel J, Mao Y, Sparks G, Harrington M, Peddinti R, Beyer EC. Insights image for "Circulating extracellular vesicles from patients with acute chest syndrome disrupt adherens junctions between endothelial cells". Pediatr Res. 2021 03; 89(4):1036.
-
Gemel J, Mao Y, Lapping-Carr G, Beyer EC. Gap Junctions between Endothelial Cells Are Disrupted by Circulating Extracellular Vesicles from Sickle Cell Patients with Acute Chest Syndrome. Int J Mol Sci. 2020 Nov 24; 21(23).
-
Parilla M, Gurbuxani S. Red cell morphology in sickle cell disease. Blood. 2020 10 15; 136(16):1893.
-
Payne AB, Mehal JM, Chapman C, Haberling DL, Richardson LC, Bean CJ, Hooper WC. Trends in Sickle Cell Disease-Related Mortality in the United States, 1979 to 2017. Ann Emerg Med. 2020 09; 76(3S):S28-S36.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|